WallStreetZenWallStreetZen

NASDAQ: EVOK
Evoke Pharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Evoke Pharma earnings were -$5.2M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest EVOK earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$1.2M, down 26.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, EVOK reported annual earnings of -$5.4M, with -31.3% growth.

EVOK earnings history

Current Revenue
$14.4M
Current Earnings
-$5.2M
Current Profit Margin
-36.2%

EVOK Return on Equity

Current Company
-101.4%
Current Industry
15.1%
Current Market
35.2%
EVOK's Return on Equity (-101.4%)... subscribe to Premium to read more.
High Return on Equity Performance

EVOK undefined

Current Company
-31.9%
Current Industry
5.6%
EVOK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when EVOK announces earnings.

EVOK undefined

Current Company
-138.65%
Current Industry
9.7%
EVOK's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EVOK vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
EVOK-$4.66M-$5.23MN/A-$1.38
TXMD$625.00k$302.00k-94.88%$0.02
SXTC-$2.50M-$3.30MN/A-$2.32
CABRN/AN/AN/AN/A
AYTU-$5.06M-$13.07MN/A-$2.19
View Top Pharmaceutical Stocks

Evoke Pharma Earnings Reports & History FAQ

What were Evoke Pharma's earnings last quarter?

Evoke Pharma (NASDAQ: EVOK) reported Q3 2025 earnings per share (EPS) of -$0.45, up 52.13% year over year. Total EVOK earnings for the quarter were -$1.16 million. In the same quarter last year, Evoke Pharma's earnings per share (EPS) was -$0.94.

If you're new to stock investing, here's how to buy Evoke Pharma stock.

Is Evoke Pharma profitable or losing money?

As of the last Evoke Pharma earnings report, Evoke Pharma is currently losing money. Evoke Pharma's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$5.23 million, a 14.98% decrease year over year.

What was EVOK's earnings growth in the past year?

As of Evoke Pharma's earnings date in Q4 2025, Evoke Pharma's earnings has grown year over year. EVOK earnings in the past year totalled -$5.23 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.